ID: ALA2408380

Max Phase: Preclinical

Molecular Formula: C38H30ClNO10

Molecular Weight: 696.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1cn([C@@H]2O[C@H](COC(=O)c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H]2OC(=O)c2ccccc2)c2ccc(Cl)cc2c1=O

Standard InChI:  InChI=1S/C38H30ClNO10/c1-2-46-38(45)28-21-40(29-19-18-26(39)20-27(29)31(28)41)34-33(50-37(44)25-16-10-5-11-17-25)32(49-36(43)24-14-8-4-9-15-24)30(48-34)22-47-35(42)23-12-6-3-7-13-23/h3-21,30,32-34H,2,22H2,1H3/t30-,32-,33-,34-/m1/s1

Standard InChI Key:  MWSOQJFJGWOXEU-DWNQJFHRSA-N

Associated Targets(Human)

Glyceraldehyde-3-phosphate dehydrogenase liver 1284 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glyceraldehyde-3-phosphate dehydrogenase, glycosomal 75 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 696.11Molecular Weight (Monoisotopic): 695.1558AlogP: 6.04#Rotatable Bonds: 10
Polar Surface Area: 136.43Molecular Species: NEUTRALHBA: 11HBD: 0
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 0#RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: CX LogP: 8.42CX LogD: 8.42
Aromatic Rings: 5Heavy Atoms: 50QED Weighted: 0.13Np Likeness Score: 0.11

References

1. Leitão A, Andricopulo AD, Oliva G, Pupo MT, de Marchi AA, Vieira PC, da Silva MF, Ferreira VF, de Souza MC, Sá MM, Moraes VR, Montanari CA..  (2004)  Structure-activity relationships of novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase.,  14  (9): [PMID:15081008] [10.1016/j.bmcl.2004.02.025]
2. Soares FA, Sesti-Costa R, da Silva JS, de Souza MC, Ferreira VF, Santos Fda C, Monteiro PA, Leitão A, Montanari CA..  (2013)  Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity.,  23  (16): [PMID:23850203] [10.1016/j.bmcl.2013.06.029]

Source